Cyclic Peptide Derivative Composition for Neuropathic and Inflammatory Pain
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neuropathic and inflammatory pain are inadequate, failing to effectively address the diverse etiologies and symptoms associated with these conditions.
Innovation Solution
Development of cyclic peptide derivative compositions, represented by specific structural formulas, which can be administered to treat or prevent neuropathic and inflammatory pain by targeting the underlying mechanisms of these conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for neuropathic and inflammatory pain are used, then existing therapeutic options are available, but the treatments are inadequate and fail to effectively address the diverse etiologies and symptoms
Solution Approach 1:
The cyclic peptide derivative is designed to serve multiple therapeutic functions simultaneously - it targets both neuropathic pain and inflammatory pain pathways, addressing diverse etiologies with a single compound. The molecule's structure allows it to interact with multiple pain-related targets, providing universal applicability across different pain conditions.
Solution Approach 2:
The patent employs systematic modification of the cyclic peptide's chemical structure through varying substituents at different positions (R1-R10 groups). By changing molecular parameters such as hydrophobicity, steric bulk, and electronic properties of substituent groups, the compound's pharmacological profile is optimized to enhance both effectiveness and adaptability to different pain types.
2Reliability
If a novel cyclic peptide derivative is developed to address diverse pain conditions, then adaptability and effectiveness are improved, but the complexity of the pharmaceutical composition increases
Solution Approach 1:
The cyclic peptide derivative is structured as a core scaffold with multiple independent substituent positions (R1, R2, R3, R4, R5, R6, R7, R8, R9, R10). This segmentation allows each position to be optimized independently for specific functions - the core structure provides the essential pharmacological activity while substituent groups fine-tune selectivity and potency for different pain pathways.
Solution Approach 2:
The cyclic peptide represents a composite molecular structure combining a peptidic core framework with various organic substituent groups. This composite architecture integrates the biochemical recognition capabilities of peptides with the pharmacological versatility of small molecule drugs, achieving both high effectiveness and targeted adaptability.
Data Source
Figure 1
Figure 2
AI summary
The present disclosure provides a cyclic peptide derivative composition for treating or preventing neuropathic pain and/or inflammatory pain. The present disclosure relates to a composition comprising a compound for treating or preventing neuropathic pain and/or inflammatory pain or a pharmaceutically acceptable salt, solvate or prodrug thereof. The present disclosure also relates to method for treating or preventing neuropathic pain and/or inflammatory pain, comprising administering the composition comprising the compound or a pharmaceutically acceptable salt. The technology provided by the present disclosure can be used for a cyclic peptide derivative for modulating nervous system cell activity and a method for producing said cyclic peptide derivative.